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Abstract
Rationale—Generation of induced cardiac myocytes (iCMs) directly from fibroblasts offers 
great opportunities for cardiac disease modeling and cardiac regeneration. A major challenge of 
iCM generation is the low conversion rate of fibroblasts to fully reprogrammed iCMs, which could 
in part be attributed to unbalanced expression of reprogramming factors Gata4 (G), Mef2c (M), 
and Tbx5 (T) using the current gene delivery approach.
Objective—We aimed to establish a system to express distinct ratios of G, M, T proteins in 
fibroblasts and determine the effect of G, M, T stoichiometry on iCM reprogramming.
Methods and Results—We took advantage of the inherent feature of the polycistronic system 
and generated all possible combinations of G, M, T with identical 2A sequences in a single 
transgene. We demonstrated that each splicing order of G, M, T gave rise to distinct G, M, T 
protein expression levels. Combinations that resulted in higher protein level of Mef2c with lower 
levels of Gata4 and Tbx5 significantly enhanced reprogramming efficiency compared to separate 
G, M, T transduction. Importantly, after further optimization, the MGT vector resulted in more 
than 10-fold increase in the number of mature beating iCMs loci. Molecular characterization 
revealed that more optimal G, M, T stoichiometry correlated with higher expression of mature 
cardiac myocyte markers.
Conclusion—Our results demonstrate that stoichiometry of G, M, T protein expression 
influences the efficiency and quality of iCM reprogramming. The established optimal G, M, T 
expression condition will provide a valuable platform for future iCM studies.
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INTRODUCTION
The generation of iCM from fibroblast holds great promise for cardiac disease modeling and 
regenerative medicine1-15. However, the inefficient iCM generation has become a major 
hurdle for deciphering the mechanism of cardiac reprogramming and in vitro cardiac disease 
modeling7, 16. Although the low conversion rate of fibroblasts to reprogrammed iCMs 
suggests the existence of major rate limiting barrier(s), it might also reflect a requirement for 
a balanced expression of Gata4(G), Mef2c(M), Tbx5(T) to promote successful and complete 
reprogramming. Current iCM generation involves transducing fibroblasts with pooled 
viruses encoding the three individual reprogramming factors. This approach suffers from 
heterogeneous and uncontrollable ratios of G, M, T expression among the transduced 
fibroblasts. Inagawa et al. attempted to address this issue through the use of a polycistronic 
vector that encoded G, M, T in a single transgene; however, their study showed only a 
marginal positive effect on reprogramming efficiency when compared to use of individual 
viruses9.
Gata4, Mef2c and Tbx5 are the master regulators residing at the top of the transcriptional 
hierarchy of the cardiac gene regulatory networks17-33. During heart development, faithful 
execution of cardiac developmental processes requires a precise dosage and temporal 
expression of these three factors17-33. Disruption of this delicate balance is likely to 
compromise cardiac specification and differentiation, and cause severe cardiac 
anomalies24-26, 34-36. We therefore postulated that when G, M, T were delivered in separate 
viruses, only a subpopulation of CFs would express the optimal amounts of G, M, T 
required to trigger cardiac reprogramming. Thus we surmised that it might be possible to 
establish a more appropriate balance of G, M, T expression in non-myocytes through the use 
of splice-ordered polycistronic vectors.
In this study, we generated a complete set of polycistronic constructs containing G, M, T in 
all possible splicing orders with identical 2A sequences in a single mRNA. We found that 
each splicing order of G, M, T gave rise to distinct ratios of G, M, T protein expression, and 
significantly different reprogramming efficiencies. Upon further optimization, the most 
desirable combination resulted in a more than 10-fold increase in generation of beating 
iCMs. Importantly, at the molecular level, the more optimal G, M, T stoichiometry, defined 
by higher protein expression level of Mef2c with lower levels of Gata4 and Tbx5, correlated 
with higher expression of mature cardiac myocyte markers. Thus, our study demonstrates 
that stoichiometry of G, M, T influences both efficiency and quality of iCM induction.
METHODS
An expanded Methods section is available in the online data.
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G, M and T protein levels differ in fibroblasts expressing each of the 6 polycistronic 
constructs
To manipulate the relative levels of G, M, T protein expression, we generated 6 
polycistronic constructs with identical 2A sequences to include all possible splicing orders 
of G, M, T in a single mRNA (Fig. 1A). In a first set of experiments, we transduced cardiac 
fibroblasts (CFs) with G, M, or T retroviruses separately. Western blot analysis showed that 
G, M, or T proteins were detected at the appropriate molecular weight (Online Fig. IA). 
Next we performed western blot on CFs transduced with each of the 6 constructs and 
observed higher protein expression level when the reprogramming factor was placed at the 
5’ end vs. 3’ end of the construct (Fig. 1B,C). After normalization to the loading control, 
quantification of band intensities revealed that each construct produced distinct ratios of G, 
M, T protein expression (Fig. 1B,C and Online Fig. IB). We also determined G, M, T 
transcript levels in transduced cells (Online Fig. II). As expected, after virus infection, G, M, 
T transcript levels were significantly elevated, however the CFs expressing each of these 6 
constructs did not exhibit significant differences in G, M, T total and endogenous transcripts 
levels (Online Fig. II). These data suggest that our complete set of polycistronic vectors can 
effectively produce distinct ratios of G, M, T protein expression in transduced CFs.
Different iCM reprogramming efficiency using each of the 6 polycistronic constructs
We next sought to determine iCM reprogramming efficiency using these 6 polycistronic 
constructs. We isolated CFs from αMHC-GFP reporter mice1, 2, which express GFP in 
differentiated cardiac myocytes (CMs) but not in CFs. Thus, activation of GFP could allow 
us to follow the emergence of newly induced iCMs. Furthermore, we used cardiac 
TroponinT (cTnT) as an additional differentiated CM marker to monitor CM fate induction. 
We transduced CFs with retroviruses encoding the 6 polycistronic mRNAs. Interestingly, 
flow analysis and quantification showed that these 6 vectors resulted in significantly 
different reprogramming efficiencies as indicated by the differences in the percentage of 
αMHC-GFP+ and cTnT+ cells (Fig. 2A,B). Noticeably, only 2 vectors (MGT and MTG) 
enhanced reprogramming efficiency compared to separate G, M, T vectors while the other 4 
resulted in a decrease in reprogramming efficiency (Fig. 2A,B). Similar results were 
obtained by performing immunocytochemistry (ICC) with antibody against αMHC-GFP 
(Fig. 2C and Online Fig. III). Likewise, western blot analysis of CFs reprogrammed with the 
6 different vectors indicated that reprogramming with MGT resulted in the highest up-
regulation of αMHC-GFP and α-actinin protein expression (Fig. 2D). Based on the two 
analyzed markers, these data suggest that the 6 polycistronic constructs conferred 
differential effects on iCM induction. While the experiments were performed with neonatal 
CFs, these polycistronic vectors exhibited similar relative reprogramming efficiencies 
(based on the percentage of αMHC-GFP+ iCMs) in neonatal tail tip fibroblasts (TTFs), 
adult CFs and adult TTFs (Online Fig. IV). We then focused on the vector with the highest 
efficiency (MGT) and performed additional experiments to determine and quantify its 
reprogramming efficiency relative to that of separate G, M, T vectors (Online Fig. V, Online 
Fig. VI). Collectively, our results demonstrate that the 6 polycistronic vectors exhibit 
significantly different iCM reprogramming capacities, and a more optimal G, M, T 
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stoichiometry, defined by higher protein level of Mef2c with lower levels of Gata4 and 
Tbx5, significantly increases iCM reprogramming efficiency.
Enhancement of the quality of iCM reprogramming using MGT with antibiotic selection
To determine if a more optimal G, M, T stoichiometry of the MGT vector could be utilized 
to improve functional maturation of iCMs, we added a puromycin resistance gene in the 
vector (puro-MGT) to enable selection of transduced CFs (Fig. 3). By utilizing puro-MGT to 
reprogram freshly isolated CFs, we observed a 3-fold increase in the percentage of αMHC-
GFP+ cells and 5-fold increase in the percentage of cTnT+ cells (Fig. 3A,B). To obtain a 
global view of iCMs, we took 228 snapshots of 10X ICC pictures to cover a full well of a 
24-well plate. After stitching all pictures together, we observed a population of cells that 
were highly enriched with iCMs, which frequently aggregated to form clusters (Fig. 3C). 
These iCMs formed sarcomere structures (stained for cTnT and α-actinin) resembling the 
ones of fetal cardiac myocytes and expressed the gap junction protein Connexin43 (Cx43) at 
the cell-cell contacts (Fig. 3D). We next analyzed intracellular Ca2+ flux by Rhod3 dye 
labeling after 4 weeks of culture. With puromycin selection, around 35% of transduced cells 
showed spontaneous Ca2+ oscillations and their frequency was variable, as previously 
reported in reprogrammed iCMs11. Figure 3E shows a representative iCM-rich area 
containing 8 iCMs. Intracellular Ca2+ concentration in this area was recorded in 4 loci, and 3 
of them showed periodic Ca2+ transients (#1-3 representative traces) suggestive of advanced 
reprogramming stages, while the fourth trace showed aperiodic oscillations. The number of 
Ca2+ transient-expressing loci was increased by application of puromycin selection (Fig. 
3E). In addition to periodic Ca2+ transients, MGT-transduced iCMs showed spontaneous 
contractile activity after 3 weeks in culture (Online Movies I and II). With increase in 
culture time to 6 weeks, the number of beating iCM loci generated using the puro-MGT 
vector increased to 30-40 loci per well of a 24-well plate (Fig. 3F), which was over ten-fold 
higher than previously reported numbers of beating loci generated by using the same or 
similar reprogramming factors1, 8. Collectively, our data suggest that a more optimal 
stoichiometry of the reprogramming factors affords a more efficient and complete 
conversion of a CF into a CM fate.
Molecular characterization of reprogramming cells resulted from varied G, M, T 
stoichiometry
Next we sought to determine how G, M, T protein stoichiometry influenced iCM gene 
expression profile. We performed real time quantitative PCR (qPCR) using a set of CM and 
CF markers that were previously used to characterize iCMs3 (Fig. 4). Interestingly, the 6 
constructs led to significant differences in CM marker gene expression. The most efficient 
MGT and MTG vectors resulted in a higher upregulation of sarcomere structure genes 
Myh6, Myl7, Tnnt2, Actc1, muscle contractility genes Pln, Slc8a1, Scn5a, gap junction 
protein gene Gja1 and ion channel genes Kcnj2, Cacba1c (Fig.4). Noticeably, we observed a 
reverse correlation of upregulation of cardiac stress genes Nppa and Nppb expression with 
reprogramming efficiency (Fig.4 D,E). The four constructs that resulted in a decreased 
reprogramming efficiency upregulated Nppa and Nppb genes expression (Fig. 4D,E), 
possibly due to over-activation by high levels of Tbx5 and Gata4. In contrast, fibroblast 
markers such as Col1a1, Col3a1, Eln were all significantly downregulated with no 
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significant difference among the 6 constructs, suggesting that they exhibited a similar 
capacity to repress fibroblast markers gene expression (Fig. 4L-N). Taken together, these 
data suggest that the stoichiometry of G, M, T influences not only the efficiency of iCM 
induction, but also the activation of cardiac myocyte markers in iCMs.
DISCUSSION
In this study, we took advantage of the inherent feature of polycistronic vectors to 
manipulate the protein expression levels of cardiac reprogramming factors G, M, T, and 
reveal a critical role of G, M, T protein stoichiometry in iCM reprogramming. We 
established that the optimal G, M, and T expression for reprogramming is a relative high 
level of Mef2c expression and low levels of Gata4 and Tbx5 expression. In addition, our 
studies suggest that an optimal balance among these three reprogramming factors could 
allow more efficient and complete conversion of CFs into cardiac myocyte-like cells.
To the best of our knowledge, this is the first work that has built a complete set of 
polycistronic vectors for a reprogramming cocktail. Carey et al. has previously compared the 
iPSC reprogramming between two existing polycistronic transgenes (OSKM v.s. OKSM)37. 
They demonstrated that these two transgenes conferred differential effects on iPSC 
induction, possibly due to the differences in O (Oct4), S(Sox2), K(Klf4), M(cMyc) protein 
expression levels as a result of the splicing order of O, S, K, M37. However, the two 
transgenes were generated by different research groups in a way that the backbone of the 
vectors and the polycistronic cleavage sites were not identical. In this study, we generated a 
whole series of polycistronic constructs to include all possible splicing orders of cardiac 
reprogramming factors in the same construct with identical 2A peptides. Our studies 
demonstrated that difference in protein stoichiometry of G, M, T alone is sufficient to confer 
a significantly different effect on cardiac reprogramming outcomes. It will be important to 
determine if the inter-regulatory relationships among the three factors play a role in 
controlling and maintaining the optimal balance of G, M, T expression needed for 
reprogramming. In addition to the polycistronic system, independent approaches such as 
those utilizing promoters with different strengths to manipulate the relative levels of G, M, T 
protein expression could be undertaken to further determine the effect of stoichiometry on 
iCM reprogramming. It remains to be determined if optimized stoichiometry of human G, 
M, T could be sufficient to induce cardiac fate in human fibroblasts without the use of 
additional factors and/or microRNAs13-15. Moreover, we found that the unbalanced protein 
expression of G, M, T (when using TMG, TGM, GMT, and GTM vectors) led to an 
inefficient iCM reprogramming. While these unbalanced G, M, T combinations were 
equally capable of suppressing gene expression of fibroblast markers, they failed to robustly 
activate cardiac program; and instead induced cardiac stress genes Nppa and Nppb. Our 
results thus could explain some discrepancies among different groups that attempted G, M, 
T-mediated iCM induction 7, 9, 16. For example, similar to G, M, T expression when using 
our TGM construct, the inefficient cardiac reprogramming reported by Chen et al7 was 
likely caused by relatively high expression of Tbx5 and Gata4 as well as the enrichment for 
potential iCMs based on expression of Tbx5. The marginal effects of using a polycistronic 
construct TMG reported by Inagawa et al9 could be similarly attributed to the non-optimal 
stoichiometry of reprogramming factors.
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In spite of excitement and significant potential of iCM reprogramming in regenerative 
medicine, the low conversion rate of fibroblasts into iCMs has been a major challenge for 
future translational efforts. Although this low efficiency is expected, as it has been reported 
for other reprogramming technologies during their fledgling phase38, there are ongoing 
efforts to overcome the hurdles and to identify small molecules to replace transcription 
factors for therapeutic purposes. All of these attempts would not be fruitful without a 
consistent and reproducible platform. Our most efficient polycistronic construct that has 
been further modified by adding antibiotic selection (pMX-puro-MGT) not only eliminates 
the need for multiple constructs, providing a homogenous gene expression stoichiometry, 
but also allows for further enrichment of transduced cells with antibiotic selection. This 
platform offers a reasonable starting point for future screening and/or mechanistic studies, 
especially those that require large amounts of materials to explore genome-wide molecular 
changes that occur during reprogramming. In addition, our complete set of polycistronic 
constructs can be further used to study the optimal strategies to convert other non-myocytes 
in addition to fibroblasts into cardiac myocytes, offering insights into how stoichiometry of 
G, M, T expression can control cardiac fate acquisition under a variety of conditions.
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Nonstandard Abbreviation and Acronyms
αMHC/Myh6 alpha muscle heavy chain, also known as myosin heavy chain 6
CF cardiac fibroblast
CM cardiac myocyte
G, M, T Gata4, Mef2c, Tbx5
cTnT cardiac Troponin T
iCM induced cardiac myocyte
iPSC induced pluripotent stem cell
TTF tail tip fibroblast
O, S, K, M Oct4, Sox2, Klf4, cMyc
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• Fibroblasts can be directly reprogrammed into cardiac myocyte–like cells 
(called iCMs).
• A combination of Gata4 (G), Mef2c (M), and Tbx5 (T) is sufficient to convert 
fibroblasts into iCMs.
• Generation of iCM in vivo has been shown to improve heart function and reduce 
scar size in a mouse myocardial infarction model.
What New Information Does This Article Contribute?
• Stoichiometry of G, M, and T protein expression plays important roles in iCM 
reprogramming.
• The desirable G, M, and T expression for reprogramming is a relative high level 
of Mef2c protein expression and low levels of Gata4 and Tbx5 expression.
• An optimal balance of G, M, T could allow more efficient and complete 
conversion of fibroblasts into iCMs.
Direct conversion of fibroblasts into cardiac myocyte-like cells (iCMs) using defined 
factors such as Gata4 (G), Mef2c(M) and Tbx5(T) holds great promise for regenerative 
medicine. However, the low conversion rate and the considerable variability in iCM 
generation have hindered further mechanistic studies and optimization for clinical 
applications. We took advantage of the inherent feature of the polycistronic system and 
generated a complete set of polycistronic constructs to include all possible splicing orders 
of G, M, T in a single mRNA. Using this unique tool, we found that varying 
stoichiometry of G, M, T protein expression resulted in significant differences in iCM 
reprogramming efficiency and quality. Moreover, we found the optimal stoichiometry for 
iCM reprogramming to be a relative high level of Mef2c protein expression and low 
levels of Gata4 and Tbx5 expression. By addition of an antibiotic selection cassette to the 
optimal G, M, T combination (MGT), we further enriched population of transduced 
fibroblasts yielding an even higher efficiency of generation of functional iCMs. Our 
approach provides a valuable platform for further mechanistic studies of direct cardiac 
reprogramming.
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Figure 1. A complete set of polycistronic vectors that result in different G, M, T protein levels
(A) Diagram of the six polycistronic vectors with G, M, T in different splicing orders. 
Reprogramming factors were cloned in all possible orders (separated by identical P2A and 
T2A sequences) into the retroviral vector pMX. (B) Western blot analysis of CFs expressing 
each of the 6 different polycistronic vectors. Cell lysate was collected at 3 days post 
infection. (C) Quantification of G, M, T protein expression levels. Error bars represent 
standard error of mean. *, p<0.05; ** p<0.01.
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Figure 2. iCM reprogramming efficiencies using the 6 polycistronic vectors
(A) Representative FACS plots of cTnT+, αMHC-GFP+ and double positive iCMs. (B) 
Quantification of the FACS data. (C) Representative ICC images of iCMs generated by 
using each of the 6 constructs. Note that only 2 vectors resulted in higher reprogramming 
efficiencies relative to others. Scale bar: 200μm. *, p<0.05; ** p<0.01. (D) Western blot 
analysis of GFP and α-actinin expression in the CFs expressing each of the 6 constructs. 
Quantification of GFP and α-actinin expression from three independent experiments is 
shown in the bar graph. Error bars represent standard error of mean.
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Figure 3. Further enhancement of iCM reprogramming efficiency using puro-MGT
(A) Representative FACS plots of cTnT+, αMHC-GFP+ and double positive iCMs. (B) 
Quantification of FACS data. ** p<0.01. (C) Stitched (from 228 individual image) ICC 
picture showing iCMs (GFP positive) in one well of 24-well plate under optimized 
condition. Inset showing a representative high resolution image of an iCM cluster. (D) ICC 
of cardiac markers cTnT, α-actinin and Cx43 double labeling with αMHC-GFP. The middle 
panels are enlarged areas from the left-hand panels as indicated by the white rectangles. 
Note the striated pattern of sarcomeres in the top two middle panels and Cx43 positive spots 
at the cell-cell contacts in the bottom middle panel. Scale bar: 200μm. (E) iCM calcium 
transients measured by Rhod3 dye labeling. Each trace corresponds to the spot numbered in 
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the upper-left panel. Scale bar: 200μm. Quantification is shown in the lower left histogram. 
(F) Quantification of the number of beating iCM loci over time. Error bars represent 
standard error of mean.
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Figure 4. Gene expression analyses of CFs expressing each individual polycistronic vector
Relative expression of a panel of CM or fibroblast marker genes in CFs infected with each 
of the 6 polycistronic vectors compared with CFs infected with mock (dsRed) or pooled G
+M+T at 10 days post infections. Error bars represent standard error of mean.
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